Total Payments
$4,689
2024 Payments
$2,973
Companies
24
Transactions
289
Medicare Patients
301
Medicare Billing
$13,282
Payment Breakdown by Category
Food & Beverage$4,689 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,689 | 289 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $605.71 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $415.11 | 15 | $0 (2024) |
| Novo Nordisk Inc | $400.24 | 25 | $0 (2024) |
| ABBVIE INC. | $387.37 | 35 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $349.61 | 33 | $0 (2024) |
| PFIZER INC. | $300.18 | 18 | $0 (2024) |
| Lundbeck LLC | $277.60 | 15 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $271.77 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $230.56 | 16 | $0 (2024) |
| ITI, Inc. | $229.53 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,973 | 173 | AstraZeneca Pharmaceuticals LP ($385.55) |
| 2023 | $1,716 | 116 | Janssen Pharmaceuticals, Inc ($360.32) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 3 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.38 | General |
| 09/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: CNS | ||||||
| 09/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Neurology | ||||||
| 08/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: PAIN | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Central Nervous System | ||||||
| 08/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: VACCINES | ||||||
| 07/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 239 | 401 | $34,527 | $9,839 |
| 2022 | 3 | 62 | 65 | $10,962 | $3,443 |
Total Patients
301
Total Services
466
Medicare Billing
$13,282
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 152 | $23,992 | $6,979 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 24 | $5,436 | $1,277 | 23.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 19 | $1,520 | $657.78 | 43.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $1,060 | $454.16 | 42.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 39 | $1,526 | $317.52 | 20.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 120 | $613.00 | $89.27 | 14.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 19 | $380.00 | $64.79 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 27 | $6,642 | $2,092 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $4,152 | $1,320 | 31.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 14 | $168.00 | $30.80 | 18.3% |
About Brooke Bullard, APRN
Brooke Bullard, APRN is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2022. The National Provider Identifier (NPI) number assigned to this provider is 1871244780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Bullard, APRN has received a total of $4,689 in payments from pharmaceutical and medical device companies, with $2,973 received in 2024. These payments were reported across 289 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,689).
As a Medicare-enrolled provider, Bullard has provided services to 301 Medicare beneficiaries, totaling 466 services with total Medicare billing of $13,282. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 01/12/2022
- Last Updated 01/12/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871244780
Products in Payments
- CAPLYTA (Drug) $579.14
- REXULTI (Drug) $483.63
- INVEGA SUSTENNA (Drug) $320.66
- AIRSUPRA (Drug) $267.03
- SPRAVATO (Drug) $196.08
- Azstarys (Drug) $177.64
- QULIPTA (Drug) $169.72
- ARISTADA (Drug) $166.84
- Austedo XR (Drug) $159.31
- Rybelsus (Drug) $153.90
- PREVNAR 20 (Biological) $137.71
- VERQUVO (Drug) $133.32
- FARXIGA (Drug) $121.98
- JARDIANCE (Drug) $113.67
- UZEDY (Drug) $112.46
- UBRELVY (Drug) $110.44
- VRAYLAR (Drug) $107.21
- PERSERIS (Drug) $104.93
- Ozempic (Drug) $92.02
- MOUNJARO (Drug) $91.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Family Medicine $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Family Medicine $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Family Medicine $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Family Medicine $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Family Medicine $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261
Family Medicine $121,261